Seraxis: Funding, Investors & Team (Oct 2026)
Seraxis, a private biotechnology company established in March 2013, is based in Singapore and the United States with its GMP laboratory situated in Germantown, Maryland. The company's team of researchers has created innovative cell and encapsulation technologies with the aim of developing a viable cell therapy for insulin-dependent diabetes that offers a long-term solution without the need for immuno-suppression. Their corporate setup and approach are specifically tailored to expedite progress towards this objective, all while delivering significant value to their stakeholders.
Seraxis has raised $40.4M across 3 funding rounds on record, the most recent an undisclosed round announced in May 2025.
Seraxis Company Profile and Key Stats
Latest funding round on record: May 2025.
Seraxis Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Seraxis raised $40.0M in a Series C announced in Feb 2021.
3.3 years later, an undisclosed round of $400k was announced in Jun 2024.
11 months later, an undisclosed round was announced in May 2025 with no disclosed amount.
Seraxis Founders and Leadership Team
Contact details for the Seraxis team: 2 of 2 have an email address on file.
Start 14-day free trial →Seraxis Funding Compared to Other Biotechnology Startups
Funded Startups Like Seraxis in Biotechnology and Germantown
Companies Similar to Seraxis
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Seraxis Funding FAQs
What does Seraxis do?
Seraxis, a private biotechnology company established in March 2013, is based in Singapore and the United States with its GMP laboratory situated in Germantown, Maryland. The company's team of researchers has created innovative cell and encapsulation technologies with the aim of developing a viable cell therapy for insulin-dependent diabetes that offers a long-term solution without the need for immuno-suppression. Their corporate setup and approach are specifically tailored to expedite progress towards this objective, all while delivering significant value to their stakeholders.
How much funding has Seraxis raised?
Seraxis has raised $40.4M across 3 rounds on record.
When did Seraxis last raise funding?
Seraxis' most recent funding round on record was announced in May 2025. The amount was not disclosed.
Who founded Seraxis?
FundedIQ lists Carole Welsch (Founder) at Seraxis.
Who is the CEO of Seraxis?
William Rust is listed as CEO at Seraxis.
Where is Seraxis headquartered?
Seraxis is based in Germantown, Maryland, United States.
How many employees does Seraxis have?
Seraxis is in the 11-50 employee band.
About FundedIQ's Seraxis Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Seraxis is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.